title: Leukocytosis after Clozapine Treatment in a Patient with Chronic Schizophrenia.
abstract: Clozapine is an atypical antipsychotic drug that is approved by the US Food and Drug Administration (FDA) for the treatment of psychotic disorders. Agranulocytosis is a well-established side effect of clozapine; clozapine has also been associated with other blood dyscrasias like leukocytosis, albeit rarely. In this paper, we aim to report a case of possible clozapine-associated leukocytosis in a 41-year-old woman.
authors.affiliation: Department of Psychiatry, Kocaeli University School of Medicine, Kocaeli, Turkey.
authors.forename: Aslıhan
authors.initials: A
authors.lastname: Polat
authors.affiliation: Department of Psychiatry, Abant İzzet Baysal University School of Medicine, Bolu, Turkey.
authors.forename: Uğur
authors.initials: U
authors.lastname: Çakir
authors.affiliation: Department of Psychiatry, Kocaeli University School of Medicine, Kocaeli, Turkey.
authors.forename: Nermin
authors.initials: N
authors.lastname: Gündüz
keywords: Antipsychotics; clozapine; hematological; leukocytosis